Autolus Therapeutics (AUTL) Earnings Date, Estimates & Call Transcripts → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free AUTL Stock Alerts $4.39 +0.32 (+7.86%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryLatest Earnings DateMar. 14EstimatedActual EPS (Mar. 14) -$0.44 Missed By -$0.18 Consensus EPS (Mar. 14) -$0.26 Get Autolus Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for AUTL and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueAUTL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AUTL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Autolus Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.30)($0.30)($0.30)Q2 20241($0.29)($0.29)($0.29)Q3 20241($0.28)($0.28)($0.28)Q4 20241($0.26)($0.26)($0.26)FY 20244($1.13)($1.13)($1.13)AUTL Earnings Date and InformationAutolus Therapeutics last issued its quarterly earnings data on March 14th, 2024. The reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.26) by $0.18. Autolus Therapeutics has generated ($1.19) earnings per share over the last year (($1.19) diluted earnings per share). Earnings for Autolus Therapeutics are expected to grow in the coming year, from ($0.71) to ($0.57) per share. Read More Autolus Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript3/14/2024Q4 2023($0.26)($0.44)($0.18)($0.44)--11/2/2023Q3 2023($0.24)($0.26)($0.02)($0.26)$2.00 million$0.41 million8/3/2023Q2 2023($0.22)($0.26)($0.04)($0.26)--5/4/2023Q1 2023($0.28)($0.23)+$0.05($0.23)$1.09 million$1.29 million3/7/2023Q4 2022($0.31)($0.23)+$0.08($0.23)$4.50 million$3.83 million11/3/2022Q3 2022($0.46)($0.47)($0.01)($0.47)$0.30 million$2.37 million Get the Latest News and Ratings for AUTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Autolus Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/4/2022Q2 2022($0.42)($0.46)($0.04)($0.46)-- 5/5/2022Q1 2022($0.51)($0.41)+$0.10($0.41)$0.26 million$0.17 million 3/10/2022Q4 2021($0.49)($0.51)($0.02)($0.51)$0.27 million$0.18 million 11/2/2021Q3 2021($0.51)($0.47)+$0.04($0.47)$0.25 million$0.24 million 8/5/2021Q2 2021($0.50)($0.47)+$0.03($0.47)$0.31 million$1.65 million Autolus Therapeutics Earnings - Frequently Asked Questions When did Autolus Therapeutics announce their last quarterly earnings? Autolus Therapeutics (NASDAQ:AUTL) last announced its quarterly earning data on Thursday, March 14, 2024. Learn more on AUTL's earnings history. Did Autolus Therapeutics beat their earnings estimates last quarter? In the previous quarter, Autolus Therapeutics (NASDAQ:AUTL) missed the analysts' consensus estimate of ($0.26) by $0.18 with a reported earnings per share (EPS) of ($0.44). Learn more on analysts' earnings estimate vs. AUTL's actual earnings. How much revenue does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded annual revenue of $1.70 million. How much profit does Autolus Therapeutics generate each year? Autolus Therapeutics (NASDAQ:AUTL) has a recorded net income of -$208.38 million. AUTL has generated -$1.19 earnings per share over the last four quarters. What is Autolus Therapeutics's EPS forecast for next year? Autolus Therapeutics's earnings are expected to grow from ($0.71) per share to ($0.57) per share in the next year. More Earnings Resources from MarketBeat Related Companies: BioCryst Pharmaceuticals Earnings Results Scholar Rock Earnings Results Mesoblast Earnings Results Immatics Earnings Results Relay Therapeutics Earnings Results Cullinan Oncology Earnings Results REGENXBIO Earnings Results Vir Biotechnology Earnings Results CARGO Therapeutics Earnings Results 4D Molecular Therapeutics Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (NASDAQ:AUTL) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autolus Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
